IL4R and neoplasm: CTLs labeled with the IL4R-binding IL4RPep-1 peptide (CRKRLDRNC) using a phospholipid-based membrane anchor showed enhanced tumor homing and antitumor growth activity in mice bearing B16F10 melanoma44.